To test if maternal hemodynamics, and bioimpedance, together with the Combined Screening (maternal history, biophysical and biochemical markers), are able to identify normotensive non-obese patients at risk for preeclampsia (PE) and/or intrauterine growth restriction (IUGR) in the first trimester of gestation.
Gagliardi, G., Tiralongo, G., Lo Presti, D., Pisani, I., Farsetti, D., Vasapollo, B., et al. (2017). Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 50(5), 584-588 [10.1002/uog.17379].
Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients
Farsetti, D;Vasapollo, B;ANDREOLI, ANGELA;VALENSISE, HERBERT CARMELO CARLO
2017-01-01
Abstract
To test if maternal hemodynamics, and bioimpedance, together with the Combined Screening (maternal history, biophysical and biochemical markers), are able to identify normotensive non-obese patients at risk for preeclampsia (PE) and/or intrauterine growth restriction (IUGR) in the first trimester of gestation.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
